Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For GLE.SW
Valuation Somewhat Positive
56%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Bad
0%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA 90.73 -16.28 -175.65
Graham Fair Price 26.01 40.24 31.93
PEG -72.61 0.16 0.58
Price/Book 1.94 0.29 0.29
Price/Cash Flow inf 0.00 4.53
Prices/Earnings -34.20 7.27 11.05
Price/Sales 295.79 2.98 0.75
Price/FCF inf 0.00 4.53
Naive Interpretation member
01 - Valuation · Somewhat Positive
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin 0.00 1.00 1.00
Operating Margin 395.71 0.14 0.03
ROA 54.51 < 0.005 < 0.005
ROE < 0.005 0.01 54.93
ROIC < 0.005 < 0.005 157.14
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ 0.01 0.07 -77.72
Dividends QOQ 0.00 0.00 0.00
EBIT QOQ -0.20 0.30 49.04
EPS QOQ 0.19 0.45 140.26
FCF QOQ 0.00 -1.00 -100.00
Revenue QOQ 3.08 -0.74 -76.09
Naive Interpretation member
03 - Financial Growth · Balanced
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 0.00 0.00 0.00
Days Sales Outstanding (DSO) 49.45 0.00 inf
Inventory Turnover 0.00 0.00 0.00
Debt/Capitalization 0.85 0.73 -13.85
Quick Ratio 0.39 0.00 inf
Naive Interpretation member
04 - Leverage & Liquidity · Bad
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 83.39 84.42 1.24
Cash 413.81 272.94 -34.04
Capex -8.52 0.00 inf
Free Cash Flow 5.31 0.00 inf
Revenue 31.97 8.34 -73.92
Naive Interpretation member
05 - Per Share Metrics · Weak
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 0.39 0.00 inf
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -201.62 -37.01 81.64
Naive Interpretation Member
06 - Financial Health · Bad